These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 307856)

  • 21. Arthritis and rheumatism are neglected health priorities: a bibliometric study.
    Glazier R; Fry J; Badley E
    J Rheumatol; 2001 Apr; 28(4):706-11. PubMed ID: 11327239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Those canny Scots, Welsh wizards and 'lucky' Irish.
    Halpern S
    Health Soc Serv J; 1979 Oct; 89(4665):1384-6. PubMed ID: 10309073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
    Tilson L; Bennett K; Barry M
    Eur J Health Econ; 2005 Sep; 6(3):267-73. PubMed ID: 15977036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Socialized medicine--the patient-victim.
    Sutherland G
    Ohio Med; 1989 Aug; 85(8):607-8. PubMed ID: 2761973
    [No Abstract]   [Full Text] [Related]  

  • 25. Why the NHS should fund infertility services.
    Byrne PA; Lewis SE; Traub AI; McClure N
    Ulster Med J; 1999 May; 68(1):2-3. PubMed ID: 10489804
    [No Abstract]   [Full Text] [Related]  

  • 26. The cost of rehabilitation in rheumatic disease.
    ROBINSON HS
    J Chronic Dis; 1958 Dec; 8(6):713-8. PubMed ID: 13598783
    [No Abstract]   [Full Text] [Related]  

  • 27. Data briefing--capital costs. National Association of Health Authorities and Trusts.
    Health Serv J; 1992 Mar; 102(5293):37. PubMed ID: 10117212
    [No Abstract]   [Full Text] [Related]  

  • 28. [Organization of the rheumatism control in socialist countries].
    Altus RE
    Z Arztl Fortbild (Jena); 1973 Aug; 67(16):829-35. PubMed ID: 4544139
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors influencing hospital costs of lung cancer patients in Northern Ireland.
    Fleming I; Monaghan P; Gavin A; O'Neill C
    Eur J Health Econ; 2008 Feb; 9(1):79-86. PubMed ID: 17401593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presidential address: Queensland Branch of the Australian Medical Association.
    Lee JF
    Med J Aust; 1974 Jul; 2(3):suppl:13-6. PubMed ID: 4415188
    [No Abstract]   [Full Text] [Related]  

  • 31. Base-year expenditure analysis for programme budgeting in an RHA.
    Firth CM
    Hosp Health Serv Rev; 1979 Jan; 75(1):12-8. PubMed ID: 10240073
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost of skin cancer in England.
    Morris S; Cox B; Bosanquet N
    Eur J Health Econ; 2009 Jul; 10(3):267-73. PubMed ID: 18791757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rheumatology and balneology in the Rumanian Socialist Republic].
    Vykydal M; Stoia-Fejfarová H
    Fysiatr Revmatol Vestn; 1968 Feb; 46(1):48-50. PubMed ID: 5300156
    [No Abstract]   [Full Text] [Related]  

  • 34. Building medical care facilities in conditions of limited resources--a phased method of bringing them into operation.
    Roschin A
    World Hosp; 1975; 11(2-3):142. PubMed ID: 10238317
    [No Abstract]   [Full Text] [Related]  

  • 35. Working for patients.
    Haslock I
    Br J Rheumatol; 1989 Jun; 28(3):185-6. PubMed ID: 2786437
    [No Abstract]   [Full Text] [Related]  

  • 36. Determining priorities.
    Kinder PG
    Ulster Med J; 1978; 47 Suppl 1():59-62. PubMed ID: 307856
    [No Abstract]   [Full Text] [Related]  

  • 37. [Program of studying economic efficacy in rheumatism control].
    Zaĭtseva MP
    Vopr Revm; 1972; 12(1):3-8. PubMed ID: 4261378
    [No Abstract]   [Full Text] [Related]  

  • 38. Great medicine--pity about the cost.
    Cooke J
    Ulster Med J; 1998 Jun; 67 Suppl 1(Suppl 1):63-5. PubMed ID: 9807958
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of specialist services.
    Boyd MW
    Ulster Med J; 1978; 47 Suppl 1():17-25. PubMed ID: 354157
    [No Abstract]   [Full Text] [Related]  

  • 40. Economic issues with new rheumatologic therapeutics.
    Kavanaugh A
    Curr Opin Rheumatol; 2007 May; 19(3):272-6. PubMed ID: 17414954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.